Back to Search
Start Over
RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia
- Source :
- Leukemia Research. 111:106735
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
- Subjects :
- Male
Cancer Research
Decitabine
chemistry.chemical_compound
Antineoplastic Combined Chemotherapy Protocols
Humans
Medicine
Bone Marrow Transplantation
Retrospective Studies
Sulfonamides
business.industry
Venetoclax
Myeloid leukemia
Hematology
Middle Aged
Bridged Bicyclo Compounds, Heterocyclic
Prognosis
Combined Modality Therapy
Survival Rate
Leukemia, Myeloid, Acute
Oncology
chemistry
RUNX1
Drug Resistance, Neoplasm
Core Binding Factor Alpha 2 Subunit
Mutation
Relapsed refractory
Azacitidine
Cancer research
Female
Neoplasm Recurrence, Local
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 01452126
- Volume :
- 111
- Database :
- OpenAIRE
- Journal :
- Leukemia Research
- Accession number :
- edsair.doi.dedup.....d2b92022bb055370eee6aa8e169bb88e